secwatch.observer — SEC 8-K summary
======================================

Issuer:     DENTSPLY SIRONA Inc. (XRAY)
CIK:        0000818479
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0000818479-23-000081
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dentsply Sirona Q3 net loss $266M; lowers FY23 guidance; appoints Brian Gladden to board
--------------------------------------------------------------------------------

- Q3 net sales flat at $947M, organic sales -0.3%; GAAP net loss $266M ($1.25/share) including $302M impairment.
- Adjusted EPS $0.49, up 19.6% YoY; adjusted EBITDA margin 18.2% vs 17.5% a year ago.
- FY23 guidance lowered: organic sales growth to ~1% from ~3%; adjusted EPS to $1.80–$1.85 from $1.92–$2.02.
- Brian Gladden appointed to Board effective Jan 1, 2024, replacing retiring director Harry Kraemer Jr.
- Company plans $150M share repurchase in Q4 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818479/000081847923000081/0000818479-23-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818479/000081847923000081/xray-20231102.htm
  HTML page:      https://secwatch.observer/filing/0000818479-23-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer